| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |